AIM Blog Alzheimer’s Advocates Rally for CMS to “Fix This Mess” and Stop Blocking Access to Alzheimer’s Treatments Read Blog Post
Press Release Alzheimer’s Association, Individuals Living with Alzheimer’s Urge FDA to Grant Traditional Approval for Lecanemab Read Press Release
Press Release Alzheimer’s Advocate Testifies What Access to FDA-Approved Alzheimer’s Treatments Means Read Press Release
